[O-02] Oral Session 02 ［English］「Gene therapy, Regenerative medicine, and Therapy development」

[O-02-3] Development of heteroduplex oligonucleotides via intrathecal route from in vitro to in vivo

Kotaro Yoshioka^1,2, Mon Su Su Lei^1,2, Maho Katsuyama¹, Takayuki Kuroda¹, Kumiko Sato¹, Kie Tanaka¹, Eriko Isogai¹, Rintaro Iwata-Hara^1,2, Tetsuya Nagata^1,2, Takanori Yokota^1,2 (1.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan, 2.NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, Japan)